LI
VRTX icon

LRI Investments’s Vertex Pharmaceuticals VRTX Stock Holding History

LRI Investments’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$158K Sell
319
-66
-17% -$29.3K 0.01% 373
2026
Q1 		$172K Buy
385
+11
+3% +$5.13K 0.02% 304
2025
Q4 		$169K Buy
374
+5
+1% +$2.15K 0.01% 316
2025
Q3 		$145K Sell
369
-193
-34% -$80.7K 0.01% 348
2025
Q2 		$250K Sell
562
-170
-23% -$78.3K 0.02% 253
2025
Q1 		$355K Buy
732
+335
+84% +$156K 0.03% 197
2024
Q4 		$160K Sell
397
-438
-52% -$203K 0.02% 320
2024
Q3 		$404K Buy
835
+123
+17% +$59.1K 0.04% 177
2024
Q2 		$334K Buy
712
+701
+6,373% +$304K 0.04% 162
2024
Q1 		$4.6K Buy
+11
New +$4.65K ﹤0.01% 645

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
CTB
Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return
II
IFM Investors Melbourne, Australia $15.1B AUM 40.57% 1-Year Est. Return

LRI Investments's VRTX Position: Q2 2026 in Review

LRI Investments reduced its Vertex Pharmaceuticals (VRTX) stake by 17% in Q2 2026, selling an estimated $29.3K and leaving 319 shares worth $158K. The position accounts for 0.01% of the portfolio, ranked #373.

LRI Investments first reported a position in VRTX in Q1 2024 and has held it in 10 quarters since. The position peaked at $404K in Q3 2024. 334 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • LRI Investments held 319 shares of Vertex Pharmaceuticals worth $158K as of Q2 2026.
  • LRI Investments sold 66 Vertex Pharmaceuticals shares in Q2 2026, an estimated $29.3K.
  • Vertex Pharmaceuticals made up 0.01% of LRI Investments's portfolio in Q2 2026, its #373 holding.
  • LRI Investments first reported a position in Vertex Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
  • LRI Investments's Vertex Pharmaceuticals position peaked at $404K in Q3 2024.
  • 334 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on LRI Investments's 13F filing for Q2 2026, filed 14 Jul 2026.